The first batch of generic drug catalogues are officially released

On October 9, the State Health and Health Commission launched the Notice on the Issuance of the First Catalogue of Encouraging Generic Pharmaceuticals, which clearly listed the first batch of 33 Catalogues of Encouraging Generic Pharmaceuticals. It is suggested that the relevant departments should support clinical trials, key common technology research, priority review and approval in accordance with relevant regulations. It is known that on June 20, the official website of the Health Commission published the first list of recommendations to encourage generic drug catalogues, and a total of 34 varieties were published. Industry experts pointed out that the catalogue mainly for domestic patent expiration and patent expiration has not yet submitted registration applications, clinical supply shortage (inadequate competition) of drugs, in order to guide enterprise research and development, registration and production.
2026-09-02
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India's PV Community Comes Together at the 6th Edition Drug Safety Symposium 2026 – India Chapter to Shape the Future of Patient Safety
-
6th Drug Safety Symposium 2026 to Focus on “Beyond Algorithms & Assumptions, What Actually Matters in Pharmacovigilance”
-
BSM: Generic has obtained multiple pesticide registrations in Brazil and has begun to contribute revenue and profit
-
Roche Acquires Carmot for $3.1 Billion to Enter Obesity Drug Market
-
Two departments issued a document to guidethe strengthening of drug cases investigation and handling
-
National Health Care Commission: 50% of thecountry's public hospitals above the second level have carried out appointmentdiagnosis and treatment services
-
India starts testing a pharmaceuticalcompany's exports of cough syrup
-
Inmanar Announces Several BreakthroughSequencing Innovations
-
China's medical supplies supply securitycapabilities continue to enhance
-
244 medical device concept stocks roseindustry insiders said the process of domestic replacement is expected toaccelerate
Recommend Reading
-
Libya’s Largest Refinery Faces Full Shutdown After Five Rounds of Airstrikes
-
SIBUR’s Massive Siberian Petrochemical Complex Shuts After Drone Attack, LPG Supply Disrupted
-
FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS, Launching First CELMoD Therapy in Multiple Myeloma
-
FDA Approves Lantheus’ TAUKLARIFY for Alzheimer’s Tau PET Imaging
-
China’s Acrylic Emulsion Leaders Raise Prices by Up to 15% as Monomer Costs Surge
-
Business Society’s Market Outlook for Phthalic Anhydride on August 11, 2026: Continuing Downward Trend
-
Business Society’s Market Outlook for Propylene Oxide on August 10, 2026: Price Trends Clearly Declining
-
Phthalic Anhydride Market Insight on August 10, 2026 in China
-
Business Society’s Market Outlook for Maleic Anhydride on August 10, 2026: Volatile
-
Vendor Shipment Surge Halts Mid-October PC Price Increase